Clinical Trials Logo

Scorpion Stings clinical trials

View clinical trials related to Scorpion Stings.

Filter by:

NCT ID: NCT00696683 Completed - Clinical trials for Scorpion Sting Envenomation

Establishment of Natural History of Scorpion Envenomation

Start date: August 2004
Phase: N/A
Study type: Observational

This retrospective study was conducted to collect data from approximately 100 patients from 6 months to 18 years of age who were stung by a scorpion but were not treated with antivenom. The study consisted of a review of hospital records of patients who were admitted for intensive care management of scorpion envenomation, at the only two hospitals in North America known to admit children routinely for scorpion sting management without antivenom. The standard of care consisted of symptomatic and supportive care, including airway maintenance, fluid and electrolyte support and, if necessary, sedation.

NCT ID: NCT00685230 Completed - Clinical trials for Scorpion Sting Envenomation

Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients

Start date: May 2004
Phase: Phase 2/Phase 3
Study type: Interventional

There is no FDA approved therapy for the treatment of scorpion envenomation, Centruroides scorpion envenomation produces a pattern of neurotoxicity with a spectrum of severity ranging from trivial to life threatening. Patients stung by Centruroides scorpions develop a clinical syndrome which may require sedation with benzodiazepines and observation for 6 to 28 hours of intensive care monitoring. A safe therapy is necessary to halt the progression of symptoms early in the clinical course while avoiding the clinical deterioration that can occur en route to a tertiary facility. Alacramyn® is anticipated to be safer and more effective than the present standard of care, midazolam, and faster-acting such that the need for transport of most rural patients will be eliminated and will reduce hospitalization time. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of scorpion sting envenomation. 2. The investigational antivenom is effective as treatment of scorpion sting envenomation.

NCT ID: NCT00624078 Completed - Clinical trials for Scorpion Sting Envenomation

Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation

Start date: May 2005
Phase: Phase 2/Phase 3
Study type: Interventional

This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailable. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of scorpion sting envenomation. 2. The investigational antivenom is effective as treatment of scorpion sting envenomation.